In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.
Live at 12 PM EDT on Tuesdays
Tune in on, Facebook, LinkedIn or Twitter. Come back to this page at any time to watch a replay.
How Lessons Learned in Fighting HIV Help Us Battle COVID-19
In the Season 2 premiere, Lisa Ling checks into the virtual AIDS 2020 conference to talk with actress and HIV advocate Laverne Cox, Johnson & Johnson Chief Scientific Officer Paul Stoffels, M.D., and others about the ongoing quest for an HIV vaccine and how that’s informing research on COVID-19 vaccines.
Meet Our Host
Ling is the Executive Producer and host of "This Is Life" on CNN. She has also been a field correspondent for "The Oprah Winfrey Show" and a contributor to ABC News' "Nightline".
Special Expert Guest
Laverne Cox
Laverne Cox
Cox is a three-time Emmy-nominated actress, Emmy-winning documentary film producer and a prominent equal rights advocate and public speaker. Her groundbreaking role of Sophia Burset in the internationally acclaimed Netflix original series "Orange is The New Black" brought her to the attention of diverse audiences all over the world.
J&J Expert Guest
Dr. Stoffels is the Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson. He spearheads the research and product pipeline by leading teams across all of the company's sectors to set the company-wide innovation agenda, discovering and developing transformational healthcare solutions.
J&J Expert Guest
Macaya Douoguih, M.D., MPH
Macaya Douoguih, M.D., MPH
Dr. Douoguih is Head of Clinical Development and Medical Affairs, Vaccines at the Janssen Pharmaceutical Companies of Johnson & Johnson. She heads a team of physicians and scientists that lead the clinical development of all viral and bacterial vaccine programs, including Ebola, RSV, HIV, E. coli and COVID-19 vaccines.
Tiko Kerr, Visual Artist and HIV Activist
Tiko Kerr, Visual Artist and HIV Activist
Kerr lives and works in Vancouver, Canada. In his 35-year-long visual arts practice, he has explored painting, collage, drawing, printmaking, murals, performance, set design and art direction in film. Kerr is also an HIV activist who has committed himself to progressing issues relating to drug policy and access.
From scientists working on a potential vaccine to medically trained employees who mobilized to the front lines to help treat patients, these men and women share what most resonates for them about the unique and devastating virus, both professionally and personally.

Season 1 Episodes

    Episode 1
    April 14, 2020
    Join host Lisa Ling as she interviews scientists and healthcare workers about how vaccines work, the impact of the COVID-19 pandemic and what’s being done globally to create a novel coronavirus vaccine.
    How a COVID-19 Vaccine Might Work. Plus, How Quickly We Could Get There
    How a COVID-19 Vaccine Might Work. Plus, How Quickly We Could Get There
    Episode 2
    April 21, 2020
    Three leading scientists who have been on the frontlines of Zika, malaria and HIV give you the inside scoop on vaccine development and the process of going from lab to clinic.
    What it Takes to Create a Coronavirus Vaccine in Record Time
    What it Takes to Create a Coronavirus Vaccine in Record Time
    Episode 3
    April 28, 2020
    Lisa Ling interviews National Academies member and University Professor at the University of Connecticut, Cato Laurencin, M.D., Ph.D., to learn what his new coronavirus study reveals. Plus, what’s needed to mass-produce a vaccine and what we’ve learned from other outbreaks.
    Why is COVID-19 Hitting Minority Communities So Hard?
    Why is COVID-19 Hitting Minority Communities So Hard?
    Episode 4
    May 05, 2020
    This week we hear from two ER doctors about what they’ve learned from caring for COVID-19 patients. A renowned epidemiologist shares why testing is so important. A Nigerian doctor who recovered from Ebola herself talks about how fighting this outbreak is different. Plus, a leading scientist talks about how long vaccine immunity could last.
    What Doctors On The Front Lines of COVID-19 Are Now Saying About the Virus
    What Doctors On The Front Lines of COVID-19 Are Now Saying About the Virus
    Episode 5
    May 12, 2020
    Two nurses—one on the front lines in the ICU, and one leading the charge to advocate for her profession—talk about what caring for patients, and each other, really means right now. An activist talks about recovering from the virus and a scientist shares the challenges of creating a vaccine for clinical. Plus, Arianna Huffington and Husseini K. Manji, MD, FRCPC, discuss the other COVID-19 crisis: how it's impacting mental health.
    How Nurses Are Battling the COVID-19 Pandemic
    How Nurses Are Battling the COVID-19 Pandemic
    Episode 6
    May 19, 2020
    Lisa Ling speaks with the Chair of the Coalition for Epidemic Preparedness Innovations, a supply chain expert and the President of Global Public Affairs at UPS about what it will take to get a vaccine to the people who need it. Plus, a young Nigerian activist on her outreach efforts.
    How the Global Community is Coming Together to Battle COVID-19
    How the Global Community is Coming Together to Battle COVID-19
    Episode 7
    May 26, 2020
    In Episode 7, Lisa Ling speaks with Johnson & Johnson Chief Scientific Officer Paul Stoffels, M.D., about important advances being made in vaccine development. Former FDA Commissioner Mark McClellan, M.D., Ph.D., discusses what reopening could look like and global health leader Jonathan Quick, M.D., MPH, shares why he believes testing is critical to help manage this pandemic.
    What Our “New Normal” Might Look Like Until We Get a COVID-19 Vaccine
    What Our “New Normal” Might Look Like Until We Get a COVID-19 Vaccine
    Episode 8
    June 02, 2020
    In the season finale of The Road to a Vaccine, pandemic pioneers Paul Stoffels, M.D., and Peter Piot, M.D., Ph.D., discuss Dr. Piot’s own experience battling COVID-19. Cato Laurencin, M.D., Ph.D., a world-renowned physician and healthcare leader weighs in on how racism is a public health crisis and discusses the impact of recent protests in the midst of a pandemic. Plus, Lisa Ling talks with International Rescue Committee President and CEO Rt Hon David Miliband about how to protect refugees and other groups particularly vulnerable to the effects of the novel coronavirus.
  • What People Are Saying

      Excellent speakers. It gives a good perspective on what the nurses are dealing with. Thank you!

      Such an awesome episode!! Great panelists!!! Happy Nurses day to all nurses, especially my sister!!!

      Glad to see how leaders from J&J are supporting front liners, which is an incredible example of serving community as a first priority. Many thanks.

      Wonderful guests—thank you!

      Thank you Lisa for doing these interviews and the J&J team for providing this information. Your calm, thoughtful approach to covering these complex multi-dimensional issues is so appreciated.🌼

      Best wishes, Dr. Schuitemaker. Thanks for all the hard work, conducting number of trial activities in parallel and collaborating across the industry.

      Appreciate all the hard work of our scientists, sacrificing so much of their time. You guys are heroes!

      Amazing, we value your countless contributions to saving lives.

      Looking forward to tuning in to tomorrow's episode. Appreciate these very informative sessions. Thanks, Lisa!

      It is really brilliant to see that Johnson and Johnson are gearing up for production worldwide for the vaccines once approved by PHE.

      I love my company, worked a lot of years being an inspector. Miss not working, I'm retired now. They will find a vaccine.

      The Human Genome Project began with the same spirit. Well done J&J for reviving that collaborative working.

  • Submit a Question
    Do you have a question that you would like to have answered on an upcoming episode of The Road to a Vaccine?
This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.